SCHEMBL2022707

SCHEMBL2022707

COc1ccc(OC)c(Nc2nccn3c(N(C(=O)O)C(C)C)nnc23)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C2B O00750 2/20 0.47
▸ PIK3C2G O75747 2/20 0.47
▸ MAPT P10636 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ ZAP70 P43403 1/20 0.40
▸ KARS1 Q15046 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PDE9A O76083 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2021387 0.92 SHMT2 (0.42) PIK3C2BPIK3C2GMAPTKDM4EKMT2A
SCHEMBL2023644 0.91 MAPT (0.43) PIK3C2BPIK3C2GMAPTKDM4EKMT2A
SCHEMBL2024324 0.91 KMT2A (0.41) PIK3C2BPIK3C2GMAPTKMT2ALMNA
SCHEMBL2024539 0.90 CRHR1 (0.40) PIK3C2BPIK3C2GKMT2AMEN1MAPK1
SCHEMBL2023862 0.89 KDM4E (0.43) MAPTKDM4EKMT2ALMNAL3MBTL1
SCHEMBL2025118 0.88 RAB9A (0.46) MAPTKMT2ALMNAGAAMEN1
SCHEMBL14136760 0.82 PIK3C2B (0.46) PIK3C2BPIK3C2GMAPTKDM4EKMT2A
SCHEMBL2019656 0.81 SRC (0.39) ZAP70KARS1
SCHEMBL2024818 0.81 ZAP70 (0.47) KDM4EZAP70KARS1
SCHEMBL2022481 0.80 RXFP1 (0.42) KMT2AGAAMEN1ZAP70KARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds ARQULE, INC. (US) 2011-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds MKI67, TP53, THPO PIK3C2B 1600/4885PIK3C2G 2848/4885MAPT 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback